Egypt’s Medical Device Sector Gears Up for Localization and Global Recognition
Egypt’s medical device industry is witnessing a major transformation, driven by government-backed localization efforts, international partnerships, and improved regulatory frameworks. As part of its Vision 2030 goals, the country is making strides to reduce dependence on imports, promote domestic manufacturing, and attract foreign investments into its healthcare sector.
In February 2025, Egypt signed a landmark agreement with China-based Mindray to establish the country’s first locally manufactured ultrasound device factory. The project aims to produce 2,500 ultrasound units annually, with the first devices expected to roll out by mid-2025. This initiative also includes training Egyptian engineers, thereby facilitating technology transfer and skill development in the diagnostic imaging segment.
Meanwhile, GE HealthCare has partnered with Egyptian authorities to explore local production of radiopaque agents and ultrasound equipment, aiming to enhance diagnostic infrastructure. This aligns with broader plans to foster self-reliance and increase public sector access to advanced imaging technologies.
Complementing these developments, the Egyptian Drug Authority (EDA) achieved a significant regulatory milestone in December 2024. The World Health Organization (WHO) awarded Egypt Maturity Level 3 status in medicines and vaccines regulation—the highest level achieved by any African nation. This recognition validates the country’s capacity in product authorization, safety surveillance, and post-market monitoring. The move boosts Egypt’s global credibility, positioning it as a hub for medical technology approvals and regulatory excellence.
In addition to building local capacity, Egypt is tightening its grip on import control to ensure patient safety. In early 2024, the Ministry of Health introduced new regulatory requirements for imported medical devices. These include mandatory post-market surveillance, timely reporting of adverse events, and stricter documentation procedures—measures designed to improve quality assurance and patient outcomes.
Adding to the momentum, Philips Healthcare showcased its latest innovations at the Africa Health ExCon held in Cairo. The company introduced its Zenition 90 mobile C-arm and Compact 5000 ultrasound systems, emphasizing their portability, automation features, and alignment with Egypt’s healthcare reform goals. These devices support cardiac, vascular, and OB/GYN imaging, and contribute to the country’s aim of decentralizing healthcare delivery.
As Egypt works to strengthen its health system infrastructure, the medical device market is forecast to grow steadily over the next decade. This growth is supported by increasing public health investments, rising demand for diagnostic tools, and international collaborations with leading players such as Medtronic, Siemens Healthineers, and Johnson & Johnson.
Industry experts believe that the blend of regulatory maturity, manufacturing potential, and technology integration positions Egypt as an emerging leader in the Middle East and Africa’s healthcare landscape. For investors and manufacturers, the Egyptian medical device market now offers enhanced access, regulatory clarity, and long-term growth potential.
